Loading...
Loading...
INVO| Name | Value |
|---|---|
| Revenues | 6.5B |
| Cost of Revenue | 3.7B |
| Gross Profit | 2.9B |
| Operating Expense | 11.0B |
| Operating I/L | -8.1B |
| Other Income/Expense | -1.0B |
| Interest Income | 0.0B |
| Pretax | -9.1B |
| Income Tax Expense | -0.0B |
| Net Income/Loss | -9.3B |
INVO Bioscience, Inc. is a commercial-stage fertility company specializing in assisted reproductive technology solutions. Its flagship product, the INVOcell, is a medical device that facilitates fertilization and early embryo development within the woman's body. The company generates revenue by providing this innovative technology to fertility clinics and healthcare facilities worldwide.
